Pain Research and Management / 2019 / Article / Tab 4

Research Article

A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy

Table 4

VAS scores of the study sample categorized by mild, moderate, and severe levels at baseline and at the four assessment periods.

Pain score (VAS)Fraction of study sample
Baseline (N = 240)7 days (N = 240)3 months (N = 222)4 months (N = 208)6 months (N = 209)Last reported (N = 240)

0–3 (mild pain) (%)07067615857
4–6 (moderate pain) (%)9273035%3637
7–10 (severe pain) (%)9133466
Average sample VAS8.232.862.963.13′3.253.31

The last column is data from the last-observed value of all subjects.

You are browsing a BETA version of Click here to switch back to the original design.